TrialJNCI cancer spectrum2025

REaCT-5G: a randomized trial of bone pain with 5-day filgrastim vs pegfilgrastim for neutropenia in breast cancer.

Terry L Ng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.